RNAble Israeli Company
RNAble is developing novel compounds that alter RNA stability through modulation of RNA epitranscriptomics for the treatment of specific cancers and rare genetic diseases with nonsense mutations.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
{
$el.querySelectorAll('a').forEach(link => {
link.target = '_blank';
link.rel = 'noopener noreferrer';
});
})"
class="ai-alternatives-content prose prose-sm dark:prose-invert prose-headings:text-gray-900 dark:prose-headings:text-gray-100 prose-p:text-gray-700 dark:prose-p:text-gray-300 prose-strong:text-gray-900 dark:prose-strong:text-gray-100 max-w-none [&>h2]:mb-4 [&>h2]:mt-8 [&>h3]:mb-3 [&>h3]:mt-6 [&>p]:mb-4 [&>ul>li]:my-2 [&>ul]:space-y-3"
>
Suggest an Alternative
Office Locations
Ness Ziona, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/rnable
External links are provided for reference and verification purposes.